Global Payments Quote - GLO | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Germany
TG
Global Payments Inc (GLO) Share Price

Global Payments Inc (GLO)

109.40

0.90

(0.83%)

Closed December 17 3:00PM

Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

109.40

Bid

108.30

Ask

110.45

Volume

178

108.40 Day's Range 109.05

82.38 52 Week Range 130.20

Market Cap

Previous Close

108.50

Open

108.40

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

254

Shares Outstanding

254,494,835

Dividend Yield

-

PE Ratio

29.60

Earnings Per Share (EPS)

3.88

Revenue

9.65B

Net Profit

986.23M

Sector

Business Services, Nec

Industry

Business Services, Nec

Website

www.globalpayments.com

Headquarters

Atlanta, Georgia, USA

Founded

-

Global Payments Inc is listed in the Business Services sector of the Tradegate (DE) with ticker GLO. The last closing price for Global Payments was 108.50 €. Over the last year, Global Payments shares have traded in a share price range of 82.38 € to 130.20 €.

Global Payments currently has 254,494,835 shares outstanding. The market capitalization of Global Payments is 27.61 € billion. Global Payments has a price to earnings ratio (PE ratio) of 29.60.

American Stock Exchange Announces 2006 Year-End Results

Amex New ETF Listings Surge 100%; Amex Launches New Electronic Trading Platform; NEW YORK, Jan. 8 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today released its 2006 year-end...

American Stock Exchange Launches Clough Global Opportunities Fund By Clough Capital Partners L.P. And Alps Mutual Funds Service

Clough Capital Partners L.P. With Alps Mutual Funds Services, Inc. Launches Third Closed-End Fund On The Amex NEW YORK, April 26 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R...

Holding(s) in Company

RNS Number:7438U Glotel PLC 28 January 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) NAME OF COMPANY GLOTEL PLC 2) NAME OF SHAREHOLDER HAVING A MAJOR...

Holding(s) in Company

RNS Number:7026U Glotel PLC 27 January 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) NAME OF COMPANY GLOTEL PLC 2) NAME OF SHAREHOLDER HAVING A MAJOR...

Director Shareholding

RNS Number:6374U Glotel PLC 26 January 2004 Andy Baker sold, on 23 January 2003, 100,000 ordinary 5p shares at 100p. Following the sale of these shares Andy Baker is now interested in...

Holding(s) in Company

RNS Number:2859U Glotel PLC 15 January 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) NAME OF COMPANY GLOTEL PLC 2) NAME OF SHAREHOLDER HAVING A MAJOR...

Interim Results

RNS Number:1728S Glotel PLC 18 November 2003 18 November 2003 Glotel Plc Interim Results for the six months to 30 September 2003 Highlights * Improved trading conditions and...

Notice of Results

RNS Number:5416R Glotel PLC 31 October 2003 31 October 2003 Glotel Plc Notice of Interim Results Glotel Plc will be announcing its interim results for the six months ended 30...

Director Shareholding

RNS Number:5412R Glotel PLC 31 October 2003 Glotel Plc Pursuant to the Founders' Salary Sacrifice Scheme (the "Scheme") established in February 2002, the Company has received notice...

Result of AGM

RNS Number:9748P Glotel PLC 19 September 2003 Glotel PLC Documents available for inspection at the Document Viewing Facility Glotel plc announces that at its 2003 AGM, held...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.75	-0.680889695869	110.15	111.3	108.35	96	110.05176715	DE
4	1.6	1.48423005566	107.8	113.85	107.8	183	111.03973805	DE
12	12.04	12.3664749384	97.36	113.85	86.24	254	99.52312021	DE
26	21.04	23.811679493	88.36	113.85	82.38	216	96.82486776	DE
52	-7	-6.01374570447	116.4	130.19999	82.38	184	102.96291113	DE
156	-0.5	-0.454959053685	109.9	135.95	82.38	111	107.14108925	DE
260	-61.36	-35.9334738815	170.76	183.6	82.38	104	111.56148805	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
J9AVERSES AI Inc	0.8565 € (171.56%)	408.71k
1UR1Bee Vectoring Technologies International Inc	0.007 € (75.00%)	365.27k
O5FRezolve AI Ltd	3.14 € (55.45%)	486.58k
M5VEhealth Inc Dl 01	7.405 € (42.27%)	5.93k
R1EAEV Resources Ltd	0.0014 € (40.00%)	285k
L7C2Windfall Geotek Inc	0.005 € (-61.54%)	200
0PV2Moovly Media Inc	0.002 € (-50.00%)	7k
28W0Aston Minerals Limited	0.003 € (-45.45%)	24k
KASHIntellabridge Technology Corp	0.017 € (-40.35%)	92.68k
R3QRenewable Energy Corporation	0.32 € (-37.56%)	63k
AXIAtos SE	0.0017 € (-10.53%)	832.56M
D7GNel ASA	0.2601 € (3.63%)	6.57M
RQ0DWave Quantum Inc	7.992 € (16.50%)	3.73M
BT81PowerHouse Energy Group Plc	0.0122 € (-7.58%)	1.42M
DI6Distribuidora Internacional De Alimentacion SA	0.0162 € (1.25%)	1.16M

JMoneyHoops

JMoneyHoops 31 seconds ago

Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ

dstock07734

dstock07734 35 seconds ago

KILLAZILLA

KILLAZILLA 1 minute ago

DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......

gitreal

gitreal 1 minute ago

...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i

flipper44

flipper44 2 minutes ago

Those people know we can still see them, right?

awesomed007

awesomed007 2 minutes ago

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

awesomed007

awesomed007 3 minutes ago

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

Eatatjoes

Eatatjoes 3 minutes ago

Paul Malec of Deer Park, NY

fuagf

fuagf 3 minutes ago

Yeps, yeps and yeps. Good ones.

NoMoDo

NoMoDo 3 minutes ago

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.

manibiotech

manibiotech 3 minutes ago

Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you

1vman

1vman 4 minutes ago

*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔

janice shell

janice shell 4 minutes ago

First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so

HappyAlways

HappyAlways 5 minutes ago

I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t

TheDane

TheDane 6 minutes ago

Not only did it hold but it’s on the way back up.

OnTrack444

OnTrack444 6 minutes ago

Might see a dime after the RS!

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!! Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!! GLTY

manibiotech

manibiotech 7 minutes ago

Interesting for sure but not conclusive which he repeat every day

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience

FACT-MASTER

FACT-MASTER 8 minutes ago

Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i

arizona1

arizona1 8 minutes ago

Never trumpers are hilarious and brilliant too.

jimr1717

jimr1717 9 minutes ago

“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is

NoMoDo

NoMoDo 10 minutes ago

If we don't see a dime, I will be shocked.

Slyhunter

Slyhunter 10 minutes ago

I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is

nfrequent

nfrequent 10 minutes ago

Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/

XMaster2023

XMaster2023 11 minutes ago

Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will

Global Payments

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions